AN UNUSUAL CASE OF RAPIDLY PROGRESSIVE PULMONARY MUCORMYCOSIS IN A CHILD WITH NEWLY DIAGNOSED TYPE 1 DIABETES MELLITUS (ESPID 2026) - May 28, 2026 - Abstract #EPV-0989; Pres time: Jun 1, 2026; 07:00 AM - 07:00 PM; Location: E-Poster Area; "Patient was immediately started on liposomal amphotericin B and isavuconazole, alongside ceftriaxone and oseltamivir for co-infections. Learning Points/Discussion This case highlights the challenges of managing mucormycosis in critically ill children and the devastating progression despite early initiation of antifungal therapy. The presence of influenza and MSSA infection, likely facilitated the invasive nature of mucormycosis, emphasizing the need for early and aggressive interventions to reduce morbidity and mortality."
Clinical • Infectious Disease • Influenza • Septic Shock
|
|
Paret M. 1; Dresner E. 1; Stein M. 1
|